These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3732056)

  • 1. Phase II trials in cancer: present status and analysis methods.
    Lee YJ
    Drugs Exp Clin Res; 1986; 12(1-3):57-71. PubMed ID: 3732056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential methotrexate plus 5-FU in advanced breast and colorectal cancers: a phase II study.
    Kaye SB; Sangster G; Hutcheon A; Habeshaw T; Crossling F; Ferguson C; McArdle C; Smith D; George WD; Calman KC
    Cancer Treat Rep; 1984 Mar; 68(3):547-8. PubMed ID: 6704984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Design and analysis of phase II trials in oncology with a group sequential method, the triangular test].
    Bellissant E; Bénichou J; Chastang C
    Therapie; 1991; 46(1):21-7. PubMed ID: 2020920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical drug development: an analysis of phase II trials, 1970-1985.
    Marsoni S; Hoth D; Simon R; Leyland-Jones B; De Rosa M; Wittes RE
    Cancer Treat Rep; 1987 Jan; 71(1):71-80. PubMed ID: 3791270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboplatin in combination therapy for metastatic breast cancer.
    Perez EA
    Oncologist; 2004; 9(5):518-27. PubMed ID: 15477636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of phase II trial designs used in studies of molecular targeted agents: outcomes and predictors of success in phase III.
    El-Maraghi RH; Eisenhauer EA
    J Clin Oncol; 2008 Mar; 26(8):1346-54. PubMed ID: 18285606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eastern Cooperative Oncology Group phase II studies in advanced measurable colorectal cancer. I. Razoxane, Yoshi-864, piperazinedione, and lomustine.
    Douglass HO; MacIntyre JM; Kaufman J; Von Hoff D; Engstrom PF; Klaassen D
    Cancer Treat Rep; 1985 May; 69(5):543-5. PubMed ID: 2988774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase II designs in cancer clinical trials: current status and future directions.
    Lee JJ; Feng L
    J Clin Oncol; 2005 Jul; 23(19):4450-7. PubMed ID: 15994154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designs for group sequential phase II clinical trials.
    Chang MN; Therneau TM; Wieand HS; Cha SS
    Biometrics; 1987 Dec; 43(4):865-74. PubMed ID: 3427171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language.
    Glynne-Jones R; Mawdsley S; Novell JR
    Colorectal Dis; 2006 Nov; 8(9):800-7. PubMed ID: 17032329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of chlorozotocin in the treatment of advanced colorectal cancer.
    Lawton JO; Giles GR; Hall J; MacAdam A; Hall R; Matheson T; Bird G
    Cancer Treat Rep; 1981; 65(1-2):13-15. PubMed ID: 6452945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease.
    Benson AB
    Clin Cancer Res; 2007 Nov; 13(22 Pt 2):6913s-20s. PubMed ID: 18006800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
    Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
    Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing an experimental agent to a standard agent: relative merits of a one-arm or randomized two-arm Phase II design.
    Taylor JM; Braun TM; Li Z
    Clin Trials; 2006; 3(4):335-48. PubMed ID: 17060208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How large should a phase II trial of a new drug be?
    Simon R
    Cancer Treat Rep; 1987 Nov; 71(11):1079-85. PubMed ID: 3315196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent proposals for early stage clinical trials of cancer].
    Ohashi Y
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():292-4. PubMed ID: 7986106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS).
    James RD; Donaldson D; Gray R; Northover JM; Stenning SP; Taylor I;
    Br J Surg; 2003 Oct; 90(10):1200-12. PubMed ID: 14515287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer.
    Cantrell JE; Brunet R; Lagarde C; Schein PS; Smith FP
    Cancer Treat Rep; 1982 Jul; 66(7):1563-5. PubMed ID: 7093972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.